Xanthi Tsiafaki

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

Vassilis Georgoulias, E. Papadakis, A. Alexopoulos et al. · The Lancet · 2001 · 344 citations

Non-platinum-based Chemotherapy, Medicine, Metronomic Therapy +9

Vinorelbine Plus Cisplatin Versus Docetaxel Plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Randomized Trial

Vassilis Georgoulias, Alexandros Ardavanis, Xanthi Tsiafaki et al. · Journal of Clinical Oncology · 2005 · 163 citations · Full text

Advanced Nsclc, Oncology, Medicine +11

A multicenter randomized clinical trial comparing paclitaxel–cisplatin–etoposide versus cisplatin–etoposide as first-line treatment in patients with small-cell lung cancer

Dimitriοs Mavroudis, E. Papadakis, M. Veslemes et al. · Annals of Oncology · 2001 · 159 citations · Full text

Paclitaxel–cisplatin–etoposide Versus Cisplatin–etoposide, Medicine, Metronomic Therapy +10

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial

Vassilis Georgoulias, George Samonis, E. Papadakis et al. · Lung Cancer · 2001 · 37 citations

Medicine, Clinical Trials, Bronchial Neoplasm +10

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study

Stylianos Kakolyris, E. Papadakis, Xanthi Tsiafaki et al. · Lung Cancer · 2001 · 35 citations

Second-line Treatment, Oncology, Rhg-csf Support +6